This research study is evaluating an educational intervention for breast cancer survivors who have experienced changes in sexual function after ovarian suppression treatment to reduce the risk of breast cancer recurrence.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in Sexual Function (FSFI)
Timeframe: Paired t-test (Wilcoxon signed-rank test) Baseline to 2 Month Follow-up